Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bajetta

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Oncology Reports|May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosisN Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews|April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyE Bajetta, N Zilembo, R Buzzoni, et al.
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
Haematologica|September 1, 1984
Management of infections in immunocompromised cancer patientsE Bajetta, G Gasparini, S Monfardini, et al.
American Journal of Clinical Oncology|August 1, 1988
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancerC Verusio, E Bajetta, L Ferrari, et al.
Cancer Clinical Trials|January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancerG Tancini, E Bajetta, S Marchini, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer]H Sommer, B Pröhl-Steimer, E Bajetta, et al.
Tumori|July 30, 1999
Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility studyM Di Bartolomeo, E Bajetta, R Buzzoni, et al.
Tumori|January 1, 1973
[Therapy of metastatic mammary carcinoma with cyclophosphamide, methotrex ate, vincristine and fluorouracil ]M De Lena, G M De Palo, G Bonadonna, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Oncology Reports|May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosisN Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews|April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyE Bajetta, N Zilembo, R Buzzoni, et al.
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
Haematologica|September 1, 1984
Management of infections in immunocompromised cancer patientsE Bajetta, G Gasparini, S Monfardini, et al.
American Journal of Clinical Oncology|August 1, 1988
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancerC Verusio, E Bajetta, L Ferrari, et al.
Cancer Clinical Trials|January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancerG Tancini, E Bajetta, S Marchini, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer]H Sommer, B Pröhl-Steimer, E Bajetta, et al.
Tumori|July 30, 1999
Integrated treatment with doxifluridine and radiotherapy in recurrent or primary unresectable rectal cancer. A feasibility studyM Di Bartolomeo, E Bajetta, R Buzzoni, et al.
Tumori|January 1, 1973
[Therapy of metastatic mammary carcinoma with cyclophosphamide, methotrex ate, vincristine and fluorouracil ]M De Lena, G M De Palo, G Bonadonna, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Pageof 22